论文部分内容阅读
随着化疗方案的完善,急性髓性白血病的完全缓解率不断增加。然而无病长生存(disease free survival,D FS)的患者仍然有限,影响患者长生存的主要原因就是微小残留病(m ini-m alresidualdisease,M RD)导致的复发,即便连造血干细胞移植仍存在复发的风险。树突状细胞(dendritic cel
With the improvement of chemotherapy, the complete remission rate of acute myelogenous leukemia is increasing. However, patients with disease-free survival (DFS) are still limited, and the primary reason for long-term survival is the recurrence caused by m RD, even with hematopoietic stem cell transplantation The risk of recurrence. Dendritic cells (dendritic cel